SIMONA AG O.N./ DE000A3E5CP0 /
7/24/2024 3:13:40 PM | Chg. - | Volume | Bid9:02:13 AM | Ask9:02:13 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
66.500EUR | - | 0 Turnover: 0.000 |
63.000Bid Size: 63 | 67.000Ask Size: 22 | 378 mill.EUR | 2.70% | 9.71 |
GlobeNewswire
6/24
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results ...
GlobeNewswire
5/14
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
5/7
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and ...
GlobeNewswire
5/2
Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
GlobeNewswire
4/30
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 F...
GlobeNewswire
4/23
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contrace...
GlobeNewswire
4/11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
3/28
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
GlobeNewswire
3/21
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webc...
GlobeNewswire
2/23
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
GlobeNewswire
2/22
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISS...
GlobeNewswire
1/31
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cre...